Investor Justin Branham owns 5.1% of Lisata

LISATA THERAPEUTICS, INC.

Rhea-AI Filing Summary

LISATA THERAPEUTICS, INC. (LSTA) has a new large shareholder disclosure. Investor Justin Branham filed a Schedule 13G reporting beneficial ownership of 462,148.68 shares of Lisata Therapeutics common stock, par value $0.001 per share. This position represents 5.1% of the outstanding common stock.

Branham reports sole voting and dispositive power over all 462,148.68 shares and no shared voting or dispositive power. The filing identifies Branham as a United States citizen and lists the holding as common stock only.

Key Figures

Shares beneficially owned: 462,148.68 shares of common stock Percent of class: 5.1% Sole voting power: 462,148.68 shares +3 more

6 metrics

Shares beneficially owned 462,148.68 shares of common stock Amount beneficially owned by Justin Branham as reported in Item 4(a)

Percent of class 5.1% Percentage of Lisata Therapeutics, Inc. common stock class held by Justin Branham

Sole voting power 462,148.68 shares Shares over which Justin Branham has sole power to vote or direct the vote

Shared voting power 0 shares Shares over which Justin Branham has shared power to vote or direct the vote

Sole dispositive power 462,148.68 shares Shares over which Justin Branham has sole power to dispose or direct the disposition

Shared dispositive power 0 shares Shares over which Justin Branham has shared power to dispose or direct the disposition

Key Terms

Schedule 13G, beneficially owned, Sole Voting Power, dispositive power

4 terms

Schedule 13G regulatory

"Investor Justin Branham filed a Schedule 13G reporting beneficial ownership"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

beneficially owned financial

"Item 4. | Ownership (a) | Amount beneficially owned: 462,148.68"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Sole Voting Power financial

"5 | Sole Voting Power 462,148.68 6 | Shared Voting Power 0.00"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

dispositive power financial

"Sole Dispositive Power 462,148.68 8 | Shared Dispositive Power 0.00"

Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What percentage of LISATA THERAPEUTICS, INC. (LSTA) does Justin Branham own according to this Schedule 13G?

Justin Branham reports beneficial ownership of 5.1% of Lisata Therapeutics, Inc. common stock. This corresponds to 462,148.68 shares of common stock, as disclosed in the Schedule 13G ownership section.

How many LSTA shares does Justin Branham beneficially own?

Justin Branham beneficially owns 462,148.68 shares of Lisata Therapeutics, Inc. common stock. The Schedule 13G states this amount as both the total shares beneficially owned and the shares over which he has sole voting and dispositive power.

Does Justin Branham have sole or shared voting power over his LSTA shares?

Justin Branham reports sole voting power over 462,148.68 shares of Lisata Therapeutics, Inc. common stock and 0 shares with shared voting power. He likewise has sole dispositive power over 462,148.68 shares and no shared dispositive power.

What class of securities of LSTA is reported in this Schedule 13G?

The filing covers Common Stock, par value $0.001 per share of Lisata Therapeutics, Inc. This is the only class of securities referenced in the ownership disclosure.

Who is the beneficial owner named in this LSTA Schedule 13G and what is their status?

The beneficial owner is Justin Branham, identified with the title “Investor” and citizenship in the United States. He reports beneficial ownership of 462,148.68 shares, representing 5.1% of Lisata Therapeutics, Inc. common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/26/2026 - 01:02 PM EDT Accepted by SEC EDGAR 08/26/2026 - 01:02 PM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

LISATA THERAPEUTICS, INC.

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

128058302

(CUSIP Number)

08/21/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 128058302

1

Names of Reporting Persons

Branham Justin Earl

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 462,148.68
6	Shared Voting Power 0.00
7	Sole Dispositive Power 462,148.68
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

462,148.68

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.1 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: LISATA THERAPEUTICS, INC.
(b)	Address of issuer's principal executive offices: 110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NEW JERSEY, 07920.
Item 2.
(a)	Name of person filing: Justin Branham
(b)	Address or principal business office or, if none, residence: 302 Goose Ridge Drive, Forest, VA 24551
(c)	Citizenship: United States
(d)	Title of class of securities: Common Stock, par value $0.001 per share
(e)	CUSIP Number(s): 128058302
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 462,148.68
(b)	Percent of class: 5.1 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 462,148.68
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 462,148.68
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Branham Justin Earl

Signature:	Justin Branham
Name/Title:	Investor
Date:	08/26/2026